MNKD (mannkindcorp.com) Bozor qiymatining balans qiymatiga nisbati

MannKind Corp (MNKD) kompaniyasining rasmiy ramzlari

MannKind Corporation (MNKD) noyob Technosphere yetkazib berish tizimini ishlab chiqqan quruq kukun molekulyar muhandisligi sohasidagi innovatordir. Kam uchraydigan kasalliklar uchun terapiyalarni moslashtirish orqali MannKind Corporation (MNKD) sanoat gigantlari bilan narxlar urushidan qochib, maxsus nishani egallagan. GURU.Markets platformasidagi kompaniyaning narx harakatlari grafigi -15.51 darajasini ko'rsatmoqda. Biznesning muvaffaqiyati patent himoyasi va shifokorlarning inhalatsiya insulinini tan olishiga bog'liq.

MNKD Afrezza: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 29.10.2026 oraligʻida

MannKind Corp (MNKD) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi MannKind Corporation|MNKD - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati MannKind Corp.|MNKD - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati MannKind|MNKD - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati mannkindcorp.com|MNKD - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati MannKind Corporation|MNKD - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati MannKind Corp.|MNKD - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar MannKind Corp.|MNKD - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari MannKind
Kompaniyaning dastlabki tahlili:MannKind Corporation - MNKD
MannKind Corp. original mahsuloti

Technosphere platformasining monetizatsiyasi va kam uchraydigan kasalliklar uchun dori vositalarini ishlab chiqish MannKind Corporation (MNKD) kompaniyasining investitsiya jozibadorligini oshirmoqda, bu esa sof aktivlardan yuqori bo'lgan bozor qiymati premiumida aks etgan. Kompaniyaning bozor qiymatining balans qiymatiga nisbati ko'rsatkichidagi -15.51 joriy qiymati bozorning kelajakdagi royalti to'lovlariga bo'lgan ishonchini namoyish etadi, bu esa investorlarga intellektual kapital uchun balans qiymatiga nisbatan to'langan premium miqdorini baholash imkonini beradi.

Asosiy raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati Haleon plc|KVUE (kenvue.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Amphastar Corp (AMPH) - Kapitallashuvning sof aktivlarga nisbati|PCRX (Pacira BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AQST (Aquestive Therapeutics Inc)|SCPH: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HYFT (ipatherapeutics.com)|ABVC BioPharma, Inc. - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Cumberland Pharmaceuticals Inc CPIX|Quantum BioPharma Limited - Bozor kapitallashuvining balans qiymatiga nisbati|FGEN: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Telomir Pharmaceuticals|RANI (Rani Therapeutics Holdings, Inc.) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Synergy CHC Corp. (SNYR)|Kapitallashuvning balans qiymatiga nisbati RLYB|Bozor qiymatining balans qiymatiga nisbati LEXX|Bozor kapitallashuvining balans qiymatiga nisbati Pulmatrix Corporation (PULM)|Bozor kapitallashuvining balans qiymatiga nisbati PTHL|Aptorum Group Ltd - Balans qiymatiga nisbatan bozor kapitallashuvi|Lyra Therapeutics (LYRA) - Bozor qiymatining balans qiymatiga nisbati|IBO - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati tnfpharma.com|Kapitallashuvning balans qiymatiga nisbati cbdMD|PRFX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Auris Medical|Bozor kapitallashuvining balans qiymatiga nisbati LIPO (Lipella Pharmaceuticals, Inc.)|Kapitallashuvning sof aktivlarga nisbati OPTN (OptiNose Inc)|PIRS: Bozor qiymatining balans qiymatiga nisbati|Procaps Group Corp - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Petros Pharmaceuticals (PTPI)|QLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati ACELYRIN (SLRN)|TFFP (TFF Pharmaceuticals Inc.) - Sof aktivlarga nisbatan bozor kapitallashuvi